Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
0.86 (HKD) • At close August 29, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Omzet
| 38.419 | 39.255 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 711.362 | 15.014 | 475.643 | 66.267 | 0 | 0 |
| Brutowinst
| -672.943 | 24.241 | -475.643 | -66.267 | 0 | 0 |
| Brutowinstmarge
| -17.516 | 0.618 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 183.387 | 649.885 | 1,465.324 | 1,826.301 | 228.219 | 45.799 |
| Algemene en administratieve kosten
| 20.39 | 52.474 | 113.07 | 345.71 | 76.429 | 17.035 |
| Verkoop- en marketingkosten
| 19.705 | 54.766 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 40.095 | 107.24 | 113.07 | 345.71 | 76.429 | 17.035 |
| Overige kosten
| 0 | -732.884 | 282.758 | -14.226 | -20.359 | -15.909 |
| Bedrijfskosten
| 263.504 | 24.241 | 1,861.152 | 2,157.785 | 284.289 | 46.925 |
| Bedrijfsresultaat
| -951.207 | -144.402 | -2,446.202 | -6,014.691 | -909.925 | -38.251 |
| Bedrijfsresultaat ratio
| -24.759 | -3.679 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 47.779 | 5.863 | -100.699 | -3,778.025 | -608.25 | -10.332 |
| Inkomen voor belasting
| -903.428 | -138.539 | -2,451.903 | -6,016.303 | -912.898 | -48.583 |
| Inkomen voor belasting ratio
| -23.515 | -3.529 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | -0.229 | 1.612 | 2.973 | 10.332 |
| Nettowinst
| -903.428 | -138.539 | -2,451.674 | -6,017.915 | -915.871 | -58.915 |
| Nettowinstmarge
| -23.515 | -3.529 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.72 | -0.11 | -2.22 | -5.37 | -0.79 | -0.051 |
| Verwaterde WPA
| -0.72 | -0.11 | -2.22 | -5.36 | -0.79 | -0.051 |
| EBITDA
| -916.54 | -45.074 | -2,386.108 | -2,226.417 | -335.041 | -61.761 |
| EBITDA ratio
| -23.856 | -1.148 | 0 | 0 | 0 | 0 |